share_log

EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

Benzinga ·  Jun 1, 2023 04:42

EF Hutton analyst Tony Butler assumes HCW Biologics (NASDAQ:HCWB) with a Buy rating and announces Price Target of $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment